Valuation: M3, Inc.

Market Cap 1,219B 7.71B 6.85B 6.41B 5.81B 10.97B 743B 11.04B 76.94B 29.92B 379B 28.94B 28.32B P/E 2027 *
23.6x
P/E 2028 * 21.1x
Enterprise Value 1,078B 6.82B 6.06B 5.67B 5.14B 9.7B 658B 9.77B 68.06B 26.47B 335B 25.61B 25.06B EV / Sales 2027 *
2.78x
EV / Sales 2028 * 2.48x
Free-Float
61.47%
Yield 2027 *
1.27%
Yield 2028 * 1.39%
1 day+1.89%
3 months+21.17%
6 months-5.80%
Current year-24.69%
Current year 8.55
Extreme 8.552
14
1 year 8.55
Extreme 8.552
15.25
3 years 8.33
Extreme 8.33
17.84
5 years 8.33
Extreme 8.33
64.37
10 years 0
Extreme 0
102
Manager TitleAgeSince
President 61 2000-09-28
Investor Relations Contact 46 -
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member 61 2000-09-28
Director/Board Member 54 2012-05-31
Director/Board Member 61 2016-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.89%-.--% - - 7.45B
+0.36%+2.14%+39.05%+153.11% 4,223B
-0.27%+0.44%+3.68%+135.24% 1,890B
-1.25%+0.42%-2.23%+42.20% 495B
+1.23%-2.64%-36.42%+42.83% 485B
+1.70%-2.35%-40.99%+79.93% 281B
-1.38%+1.44%-41.62%+26.99% 275B
+2.43%+10.74%-0.19%+206.03% 206B
-0.71%-0.57%-31.10%+50.64% 142B
+0.09%+5.55%+387.82%+2,615.79% 114B
Average +0.63%+1.85%+30.89%+372.53% 901.18B
Weighted average by Cap. +0.37%+1.50%+20.94%+162.89%

Financials

2027 *2028 *
Net sales 388B 2.45B 2.18B 2.04B 1.85B 3.49B 236B 3.51B 24.47B 9.52B 121B 9.21B 9.01B 423B 2.68B 2.38B 2.22B 2.02B 3.81B 258B 3.83B 26.7B 10.39B 132B 10.05B 9.83B
Net income 51.2B 324M 287M 269M 244M 461M 31.22B 464M 3.23B 1.26B 15.93B 1.22B 1.19B 57.11B 361M 321M 300M 272M 514M 34.82B 517M 3.6B 1.4B 17.77B 1.36B 1.33B
Net Debt -141B -889M -789M -739M -669M -1.26B -85.71B -1.27B -8.87B -3.45B -43.73B -3.34B -3.27B -168B -1.07B -946M -885M -802M -1.51B -103B -1.53B -10.63B -4.13B -52.38B -4B -3.91B
Projected Income Statement - Annual - M3, Inc.
Logo M3, Inc.
M3 Inc is a Japan-based company mainly engaged in the provision of services centering on the platform of healthcare. The Company has five business segments. Medical Platforms segment conducts marketing-related businesses in Japan utilizing the Internet and real operations centered on medical employee specialized site m3.com. Evidence Solution segment is engaged in the contract research organization (CRO) business that supports clinical development work and research, and site management organization (SMO) business that manages the clinical trial operations. Career Solutions segment is engaged in human resource services for healthcare professionals. Site Solution segment provides operational support for medical institutions and home-visit nursing services. Overseas segment provides services of medical related marketing support, research and careers, utilizing the medical employee specialized sites in the United States, the United Kingdom, China, Korea, India, France, Germany and Spain.
Employees
17,010
Trader
Investor
Global
Quality
ESG MSCI
BB
Ratings Surperformance© - M3, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
1,826.50JPY
Average target price
1,973.33JPY
Spread / Average Target
+8.04%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - M3, Inc.